Minovia Therapeutics is a clinical-stage international biotechnology company, established in hopes to bring life changing therapies to patients with Mitochondrial diseases, as fast as responsible. 
Following compassionate use cases performed in Sheba Medical hospital in Israel, using our proprietary Mitochondrial Augmentation Therapy, Minovia is now conducting the first of its kind clinical trial for Pearson syndrome, an ultra-rare pediatric disease. 

Biotechnology

Life Sciences

Therapeutics

Minovia Therapeutics

Minovia Therapeutics' headquarters in Haifa, Israel

Natalie Yivgi-Ohana

Golanit Elazar

Shmulik Polak

Nadav Eshkol

Limor Lior

Noa Sher

The Leadership Team at Minovia Therapeutics drives the strategic vision and operational execution of the company. This includes overseeing clinical trials for mitochondrial diseases, fostering a culture of innovation and collaboration, and ensuring that all departments align with the goal of delivering life-changing therapies to patients swiftly and responsibly.

Leadership Team

The Clinical and Research Team at Minovia Therapeutics is responsible for designing, managing, and executing clinical trials, including the pioneering trial for Pearson syndrome. This team orchestrates compassionate use cases, conducts critical research on Mitochondrial Augmentation Therapy, and translates scientific discoveries into actionable clinical applications to bring transformative therapies to patients with mitochondrial diseases.

Minovia Therapeutics

Org chart

Teams

Leadership Team

Clinical and Research Team

Offices

Minovia Therapeutics

Org chart

Teams

Leadership Team

Clinical and Research Team

Offices

Related companies